Cardinal Health, Inc. CAH is scheduled to report fiscal first-quarter 2025 results on Nov. 1, before the opening bell. In the ...

The FDA's latest update to its list of discontinued medical devices includes products from Cardinal Health and Intuity ...

Investors are upbeat about Cardinal Health’s Medical and Pharmaceutical offerings, which provide the company with a competitive edge in the niche space. The segment's products and services ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.28% of ...

Cardinal Health ... suite of software products focused on oncology practices. In January it augmented that technology with the $1.2 billion acquisition of Cleveland-based health IT firm Specialty ...

Beese Fulmer Investment Management Inc. lowered its position in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 13.5% in ...

Based in Dublin, Ohio, Cardinal Health, Inc. (CAH) operates as a healthcare services and products company that provides customized solutions for hospitals, pharmacies, ambulatory surgery centers ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.